These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29442507)

  • 21. Structural insights into DNA cleavage activation of CRISPR-Cas9 system.
    Huai C; Li G; Yao R; Zhang Y; Cao M; Kong L; Jia C; Yuan H; Chen H; Lu D; Huang Q
    Nat Commun; 2017 Nov; 8(1):1375. PubMed ID: 29123204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Divalent Metal Binding by SpyCas9's RuvC Active Site Contributes to Nonspecific DNA Cleavage.
    Newsom SN; Wang DS; Rostami S; Schuster I; Parameshwaran HP; Joseph YG; Qin PZ; Liu J; Rajan R
    CRISPR J; 2023 Dec; 6(6):527-542. PubMed ID: 38108519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Programmable RNA recognition and cleavage by CRISPR/Cas9.
    O'Connell MR; Oakes BL; Sternberg SH; East-Seletsky A; Kaplan M; Doudna JA
    Nature; 2014 Dec; 516(7530):263-6. PubMed ID: 25274302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences.
    Prykhozhij SV; Rajan V; Gaston D; Berman JN
    PLoS One; 2015; 10(3):e0119372. PubMed ID: 25742428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity.
    Cromwell CR; Sung K; Park J; Krysler AR; Jovel J; Kim SK; Hubbard BP
    Nat Commun; 2018 Apr; 9(1):1448. PubMed ID: 29654299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
    Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
    J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas9 Structures and Mechanisms.
    Jiang F; Doudna JA
    Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9.
    Dagdas YS; Chen JS; Sternberg SH; Doudna JA; Yildiz A
    Sci Adv; 2017 Aug; 3(8):eaao0027. PubMed ID: 28808686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryo-EM structures reveal coordinated domain motions that govern DNA cleavage by Cas9.
    Zhu X; Clarke R; Puppala AK; Chittori S; Merk A; Merrill BJ; Simonović M; Subramaniam S
    Nat Struct Mol Biol; 2019 Aug; 26(8):679-685. PubMed ID: 31285607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding the Biologist's Toolkit with CRISPR-Cas9.
    Sternberg SH; Doudna JA
    Mol Cell; 2015 May; 58(4):568-74. PubMed ID: 26000842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR RNA-guided autonomous delivery of Cas9.
    Wilkinson RA; Martin C; Nemudryi AA; Wiedenheft B
    Nat Struct Mol Biol; 2019 Jan; 26(1):14-24. PubMed ID: 30598555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
    Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
    Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric regulation of CRISPR-Cas9 for DNA-targeting and cleavage.
    Zuo Z; Liu J
    Curr Opin Struct Biol; 2020 Jun; 62():166-174. PubMed ID: 32070859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic Basis for DNA Target Specificity of CRISPR-Cas12a.
    Strohkendl I; Saifuddin FA; Rybarski JR; Finkelstein IJ; Russell R
    Mol Cell; 2018 Sep; 71(5):816-824.e3. PubMed ID: 30078724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA stretching induces Cas9 off-target activity.
    Newton MD; Taylor BJ; Driessen RPC; Roos L; Cvetesic N; Allyjaun S; Lenhard B; Cuomo ME; Rueda DS
    Nat Struct Mol Biol; 2019 Mar; 26(3):185-192. PubMed ID: 30804513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R-loop formation and conformational activation mechanisms of Cas9.
    Pacesa M; Loeff L; Querques I; Muckenfuss LM; Sawicka M; Jinek M
    Nature; 2022 Sep; 609(7925):191-196. PubMed ID: 36002571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans.
    Soppe JA; Lebbink RJ
    Trends Microbiol; 2017 Oct; 25(10):833-850. PubMed ID: 28522157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.